Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Malignant Tumor of the Breast
Interventions: DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Vinorelbine, Paclitaxel, Nab-Paclitaxel , Docetaxel, Capecitabine
Sponsor: US Oncology Research
Collaborators: Genentech, Inc.